Remission induction in a case of refractory Behçet disease with alemtuzumab.
Departments of Rheumatology, Hospital Clinico Universitario, Santiago de Compostela, Spain. evappampin@gmail.com
Eva
E
Perez-Pampin
Joaquin
J
Campos-Franco
Jorge
J
Blanco
Antonio
A
Mera
D000074323:Alemtuzumab; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001528:Behcet Syndrome / Q000188:drug therapy*; D005260:Female; D006801:Humans; D012074:Remission Induction; D055815:Young Adult
D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000074323:Alemtuzumab